Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
Showing 1,601 - 1,620 results of 21,342 for search '(( significant decrease decrease ) OR ( significant cause decrease ))', query time: 0.45s Refine Results
  1. 1601
    Type of Mutations.

    Type of Mutations. by Ashraf Attia Mahmoud (21262201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1602
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1603
    Root mean square deviation of wild-type AKR1C3 (green line) and mutant (H5Q) AKR1C3 (purple line) proteins.

    Root mean square deviation of wild-type AKR1C3 (green line) and mutant (H5Q) AKR1C3 (purple line) proteins. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1604
    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed with the ligand, NADPH).

    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed wit... by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1605
    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects.

    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1606
    Demographic characteristics of the breast cancer patients enrolled in the study.

    Demographic characteristics of the breast cancer patients enrolled in the study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1607
    FPRP values for the association between rs12529 and breast cancer risk.

    FPRP values for the association between rs12529 and breast cancer risk. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1608
    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH).

    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1609
    Representative restriction enzyme-digested products on a 2% agarose gel.

    Representative restriction enzyme-digested products on a 2% agarose gel. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1610
    Baseline characteristics of study subjects.

    Baseline characteristics of study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1611
    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).

    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1612
    Functional effects of rs12529 (H5Q) on the AKR1C3 protein.

    Functional effects of rs12529 (H5Q) on the AKR1C3 protein. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1613
    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.

    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1614
    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.

    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1615
    The clinicopathological information of the patients involved in this study.

    The clinicopathological information of the patients involved in this study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1616
    Genotypic distribution of rs12529 in the study subjects.

    Genotypic distribution of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1617
    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1618
    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1619
    Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05).

    Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

    Published 2025
    Save to List
    Saved in:
  20. 1620
    a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using systemic and local antibiotic treatment. **** - <i>p</i> values less than 0.001; ns – not significant.

    a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: